Event-Driven Stocks

Flexion Therapeutics Inc

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

Signs2 good6 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY20FY19FY18FY17FY16FY15
Revenue$20.1M$10.6M$22.5M$355,000
Operating income−$93.0M−$136.3M−$159.2M−$129.7M−$69.8M−$46.1M
Net income−$36.8M−$41.5M−$169.7M−$137.5M−$71.9M−$46.3M
Total assets$251.9M$217.6M$295.8M$441.3M$226.3M$127.1M
Total liabilities$268.6M$237.7M$185.7M$181.0M$39.2M$23.2M
Equity−$16.7M−$20.1M$110.1M$260.3M$187.0M$104.0M
EPS (diluted)
Shares out.38.6M38.0M37.6M31.7M21.6M21.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2020
Operating margin
−462.2%
Net margin
−182.8%
Return on equity
220.9%
Return on assets
−14.6%
Return on capital (ROCE)
−47.3%
Liabilities / assets
106.6%
Debt / equity
Book value / share
$-0.43
Revenue growth (YoY)
90.5%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2020
Altman Z″ (distress)
-8.23distress
Accruals / assets
13.4%high accruals
Beneish M-Score
-1.44elevated
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
36
/ 100
Profitability 20Growth 100Catalyst 33Earnings quality 0Financial strength 25

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

2 severe6 warning2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.